Trial Profile
Effect of INitial Combination Therapy With GEmigliptin and Metformin on Microbiota Change and Glycemic Control in patientS With Type 2 DIabetes aNd ObEsity (INTESTINE Study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Gemigliptin/metformin (Primary) ; Glimepiride/metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms INTESTINE
- 29 Mar 2021 Status changed from active, no longer recruiting to completed.
- 06 Apr 2020 Planned End Date changed from 31 Dec 2020 to 31 Dec 2021.
- 06 Apr 2020 Planned primary completion date changed from 30 Dec 2019 to 30 Dec 2020.